AISAP Cardio vs iCAC Device
AI Verdict
Choose AISAP Cardio if…
Choose AISAP Cardio if you require immediate, comprehensive cardiac diagnostic assessments at the point of care. This tool is ideal for clinicians needing rapid AI-powered interpretation of bedside ultrasound scans to detect structural heart disease and heart failure, including detailed measurements of valvular pathologies and ventricular function.
View AISAP Cardio →Choose iCAC Device if…
Choose iCAC Device if your primary goal is to opportunistically identify and quantify coronary artery calcium from existing, routine non-contrast chest CT scans. This solution is best suited for healthcare systems looking to leverage previously acquired imaging data to assess cardiovascular disease risk without requiring additional dedicated cardiac scans.
View iCAC Device →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AISAP Cardio | iCAC Device |
|---|---|---|
| Pricing | Not publicly available | Contact for pricing |
| Deployment | Cloud-based SaaS platform | Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform). |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AISAP CardioAISAP Cardio is designed for direct, interactive use at the point of care, empowering both novice and experienced clinicians, including non-cardiologists, to perform and interpret complex cardiac assessments. Its real-time feedback and automated reporting streamline the workflow, making advanced diagnostics accessible at the bedside.
Clinical Value
TieBoth tools offer significant and distinct clinical value. AISAP Cardio provides comprehensive, real-time cardiac diagnostic assessments at the point of care for a range of conditions. iCAC Device excels in opportunistic cardiovascular risk stratification by leveraging existing CT scans, leading to earlier detection and intervention, further supported by a CMS reimbursement pathway.
Pricing & Value
iCAC DeviceWhile both tools lack publicly available pricing, iCAC Device has a notable advantage with its established CMS reimbursement pathway for algorithmic analysis of coronary artery calcium (CAC) and aortic valve calcium (AVC). This provides a clear mechanism for financial recovery and demonstrates recognized economic value within the healthcare system.
Enterprise Readiness
AISAP CardioAISAP Cardio explicitly states its use of a 'secure, HIPAA-compliant and ISO-certified cloud' and is described as a 'vendor-agnostic and scalable solution' with seamless integration into EHR/EMR and PACS. This indicates a robust foundation for enterprise deployment and adherence to critical healthcare data security standards.
Innovation
iCAC DeviceWhile both are innovative, Tool B's ability to opportunistically identify and quantify coronary artery calcium from routine, non-gated chest CT scans (scans not originally ordered for cardiac assessment) represents a particularly novel approach. This leverages already acquired data for widespread cardiovascular risk assessment without additional patient burden or imaging.
Support & Docs
TieNeither the provided structured facts nor the web search results offer sufficient public information regarding dedicated support channels, comprehensive documentation, or structured training programs for either tool. Therefore, it is not possible to distinguish between them on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AISAP Cardio | iCAC Device |
|---|---|---|
| Name | AISAP Cardio | iCAC Device |
| Company | Aisap | Bunkerhill Health |
| Description | FDA-cleared, AI-powered point-of-care ultrasound (POCUS) software platform that provides rapid, comprehensive cardiac diagnostic assessments and measurements, enabling early detection of structural heart disease and heart failure at the bedside. | FDA-cleared AI algorithm that detects and quantifies coronary artery calcium from routine, non-contrast, non-gated chest CT scans, aiding in early cardiovascular disease detection. |
| Key Functionality | AI-powered interpretation for early cardiac disease detection, comprehensive cardiac ultrasound software package, automated generation of analyses, interpretations, and reports, assessment of valvular pathologies, measurement of Left Ventricle Ejection Fraction (LVEF), measurement of right and left ventricular dimensions, atrial areas, ascending aorta diameter, and IVC diameter. | Estimates presence and quantity of coronary artery calcium (CAC), analyzes routine, non-contrast, non-gated chest CT scans, utilizes deep-learning algorithms for analysis, provides adjunctive information to radiologists, outputs visual representation of estimated CAC segmentation, delivers exact and four-category quantitative estimates of CAC burden in Agatston units. |
| Primary Data Source | Point-of-care ultrasound (POCUS) | Routine, non-contrast, non-gated chest CT scans |
Videos
Demos, reviews, and walkthroughs featuring AISAP Cardio and iCAC Device.